Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Carcinogenesis

• Publication date

  2006-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/CARCIN/BGI240PMID 16219634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.

  2004cited by this paper
• Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma.

  2004cited by this paper
• Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells

  2003cited by this paper
• Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.

  2003cited by this paper
• Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines.

  2003cited by this paper
• Cyclooxygenase-2 Expression Does Not Correlate With Outcome in Osteosarcoma or Rhabdomyosarcoma

  2003cited by this paper
• Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

  2002cited by this paper
• Cyclooxygenase-2 Expression in Pediatric Sarcomas

  2002cited by this paper
• Selective cyclooxygenase-2 inhibitor rofecoxib (vioxx) induces expression of cell cycle arrest genes and slows tumor growth in human pancreatic cancer

  2002cited by this paper
• Autocrine/Paracrine Prostaglandin E2 Production by Non-small Cell Lung Cancer Cells Regulates Matrix Metalloproteinase-2 and CD44 in Cyclooxygenase-2-dependent Invasion*

  2002cited by this paper
• The MEK/ERK pathway mediates COX‐2‐selective NSAID‐induced apoptosis and induced COX‐2 protein expression in colorectal carcinoma cells

  2002cited by this paper
• Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells.

  2001cited by this paper
• Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice*

  2001cited by this paper
• Meloxicam inhibits the growth of non-small cell lung cancer.

  2000cited by this paper
• Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.

  2000cited by this paper
• Host cyclooxygenase-2 modulates carcinoma growth.

  2000cited by this paper
• Cyclooxygenases: structural, cellular, and molecular biology.

  2000cited by this paper
• Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

  2000cited by this paper
• The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2*

  2000cited by this paper
• Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia

  2000cited by this paper
• Role of BAX in the apoptotic response to anticancer agents.

  2000cited by this paper
• Over‐expression of cyclooxygenase‐2 in human prostate adenocarcinoma

  2000cited by this paper
• PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs.

  1999cited by this paper
• PPAR d Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs

  1999cited by this paper
• Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancer.

  1999cited by this paper
• Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen

  1999cited by this paper
• The role of cyclooxygenases in inflammation, cancer, and development

  1999cited by this paper
• Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen.

  1999cited by this paper
• Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.

  1999cited by this paper
• Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung

  1998cited by this paper
• Meloxicam inhibits the growth of colorectal cancer cells.

  1998cited by this paper
• NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.

  1998cited by this paper
• Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer.

  1998cited by this paper
• Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

  1997cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper
• The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.

  1986cited by this paper

• The Evaluation of Potential Anticancer Activity of Meloxicam—In Vitro Study on Amelanotic and Melanotic Melanoma

  2025cites this paper
• Exploring COX-Independent Pathways: A Novel Approach for Meloxicam and Other NSAIDs in Cancer and Cardiovascular Disease Treatment

  2024cites this paper
• NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer

  2024cites this paper
• Design of Etched- and Functionalized-Halloysite/Meloxicam Hybrids: A Tool for Enhancing Drug Solubility and Dissolution Rate

  2024cites this paper
• The prognostic value of COX-2 in predicting metastasis of patients with colorectal cancer: A systematic review and meta analysis

  2023cites this paper
• The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive

  2023cites this paper
• A dog with extraskeletal osteosarcoma of the salivary glands survived long-term, following surgical resection and adjuvant therapy

  2023cites this paper
• Recent and Ongoing Research into Metastatic Osteosarcoma Treatments

  2022cites this paper
• Heat Shock Proteins HSPA1 and HSP90AA1 Are Upregulated in Colorectal Polyps and Can Be Targeted in Cancer Cells by Anti-Inflammatory Oxicams with Arylpiperazine Pharmacophore and Benzoyl Moiety Substitutions at Thiazine Ring

  2021cites this paper
• Antimicrobial, antioxidant and cytotoxic activities of some analgesic or anti‐inflammatory drugs

  2021cites this paper
• Intracellular Bottom‐up Synthesis of Ultrasmall CuS Nanodots in Cancer Cells for Simultaneous Photothermal Therapy and COX‐2 Inactivation

  2021cites this paper
• Drug Repurposing Using Modularity Clustering in Drug-Drug Similarity Networks Based on Drug–Gene Interactions

  2021cites this paper
• Expression and Prognostic Characteristics of Ferroptosis-Related Genes in Colon Cancer

  2021cites this paper
• In Vitro Studies on the Influence of Meloxicam on Cytotoxic Activity Induced by Risedronate Sodium in Canine (D-17) and Human (U-2 OS) Osteosarcoma Cell Lines

  2021cites this paper
• Celecoxib and Afatinib synergistic enhance radiotherapy sensitivity on human non-small cell lung cancer A549 cells

  2020cites this paper
• Tumor Microenvironment: Molecular Players – Part B

  2020cites this paper
• Adjuvant Electrochemotherapy after Debulking in Canine Bone Osteosarcoma Infiltration.

  2020cites this paper
• The Role of Cyclooxygenase-2 in Colorectal Cancer

  2020cites this paper
• Elucidating the mechanisms of action of parecoxib in the MG-63 osteosarcoma cell line

  2020cites this paper
• Meloxicam encapsulated nanostructured colloidal self-assembly for evaluating antitumor and anti-inflammatory efficacy in 3D printed scaffolds.

  2020cites this paper
• COX-2 Signaling in the Tumor Microenvironment.

  2020cites this paper
• Selective Inhibition of Liver Cancer Cells Using Venom Peptide

  2019cites this paper
• Edinburgh Research Explorer The selective cyclooxygenase-2 inhibitor mavacoxib (Trocoxcil™) exerts anti-tumour effects in-vitro independent of cyclooxygenase-2 expression levels

  2019cites this paper
• The effect of non-steroidal anti-inflammatory drugs on osteosarcoma cells.

  2019cites this paper
• Antitumor effects of Tv1 venom peptide in liver cancer

  2019cites this paper
• Euxanthone Impairs the Metastatic Potential of Osteosarcoma by Reducing COX‐2 Expression

  2019cites this paper
• The selective cyclooxygenase-2 inhibitor mavacoxib (Trocoxil) exerts anti-tumour effects in vitro independent of cyclooxygenase-2 expression levels.

  2019cites this paper
• Inhibitory Effects of Indomethacin in Human MNNG/HOS Osteosarcoma Cell Line In Vitro

  2019cites this paper
• Mixed-ligand complexes of tenoxicam drug with some transition metal ions in presence of 2,2′-bipyridine: Synthesis, spectroscopic characterization, thermal analysis, density functional theory and in vitro cytotoxic activity

  2019cites this paper
• SND1 promotes the proliferation of osteosarcoma cells by upregulating COX‑2/PGE2 expression via activation of NF‑κB.

  2018cites this paper
• Synthesis of magnetic composite of poly (butylene succinate) and magnetite for the controlled release of meloxicam

  2018cites this paper
• Synthesis, Characterization and Cytotoxic Activity of Co(II), Ni(II), Cu(II), and Zn(II) Complexes with Nonsteroidal Antiinflamatory Drug Isoxicam as Ligand

  2018cites this paper
• Formulation and development of di-dependent microparticulate system for colon-specific drug delivery

  2017cites this paper
• Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway

  2017cites this paper
• Role of Meloxicam as a selective inhibitor of COX-2 in the inhibition of Ehrlich solid tumor growth

  2017cites this paper
• Effect of NSAIDs on the aminopeptidase activity of cultured human osteoblasts.

  2016cites this paper
• Novel triazolothiadiazines act as potent anticancer agents in liver cancer cells through Akt and ASK-1 proteins.

  2016cites this paper
• Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy

  2016cites this paper
• P50-associated COX-2 extragenic RNA (PACER) overexpression promotes proliferation and metastasis of osteosarcoma cells by activating COX-2 gene

  2016cites this paper
• Particle engineering/different film approaches for earlier absorption of meloxicam

  2016cites this paper
• Labeling and evaluation of (99m) Tc-tricarbonyl-meloxicam as a preferential COX-2 inhibitor for inflammation imaging.

  2016cites this paper
• ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib

  2015cites this paper
• Utilizing the protein corona around silica nanoparticles for dual drug loading and release.

  2015cites this paper
• Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.

  2015cites this paper
• Identification of critical genes and gene interaction networks that mediate osteosarcoma metastasis to the lungs

  2015cites this paper
• Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists’ arsenal

  2015cites this paper
• Early Tumor Response to Intraarterial or Intravenous Administration of Carboplatin to Treat Naturally Occurring Lower Urinary Tract Carcinoma in Dogs

  2015cites this paper
• Cyclooxygeanse-2 promotes metastasis in osteosarcoma

  2015cites this paper
• Primary tumour growth in an orthotopic osteosarcoma mouse model is not influenced by analgesic treatment with buprenorphine and meloxicam

  2015cites this paper
• Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists’ arsenal

  2015cites this paper
• 3d metal complexes with meloxicam as therapeutic agents in the fight against human glioblastoma multiforme and cervical carcinoma

  2015cites this paper
• Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways

  2014cites this paper
• Global Gene Expression Analysis of Canine Osteosarcoma Stem Cells Reveals a Novel Role for COX-2 in Tumour Initiation

  2014cites this paper
• Overexpression of Cyclooxygenase-2 in Malignant Peripheral Nerve Sheath Tumor and Selective Cyclooxygenase-2 Inhibitor-Induced Apoptosis by Activating Caspases in Human Malignant Peripheral Nerve Sheath Tumor Cells

  2014cites this paper
• The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro

  2014influential citation
• Can Regional Anesthesia and Analgesia Prolong Cancer Survival After Orthopaedic Oncologic Surgery?

  2014cites this paper
• Minimizing immunosuppression: an alternative approach for anesthesiologists?

  2014cites this paper
• Analysis of Gene Expression in Cyclooxygenase-2-Overexpressed Human Osteosarcoma Cell Lines

  2014cites this paper
• Effects of Naproxen on Cell Proliferation and Genotoxicity in MG-63 Osteosarcoma Cell Line

  2014influential citation
• Chapter 3 – Therapeutics

  2014cites this paper
• Recrystallized agglomerated meloxicam: evaluation of anti-nociceptive effect

  2014cites this paper
• Surface modification and evaluation of PLGA nanoparticles: the effects on cellular uptake and cell proliferation on the HT-29 cell line

  2014cites this paper
• Médicament pour prévenir, traiter ou empêcher la formation de métastases d'une tumeur à cellules géantes qui apparaît dans des parties osseuses ou molles, d'un chondrosarcome ou d'un ostéosarcome, injection locale pour l'embolisation artérielle et os artificiel

  2014cites this paper
• Development and validation of a reversed-phase liquid chromatography method for the quantification of meloxicam in liposomes

  2013cites this paper
• Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo.

  2013cites this paper
• Hybrid liposomes inhibit tumor growth and lung metastasis of murine osteosarcoma cells

  2013cites this paper
• Optimization of labeling conditions and bioevalution of 99mTc-Meloxicam for inflammation imaging

  2013cites this paper
• Enhanced Inhibitory Effect of Meloxicam, A Cyclooxygenase-2 Inhibitor Combined with Cisplatin on the Growth of Human Ovarian Cancers

  2013cites this paper
• Effect of COX and LOX inhibitors on melanoma

  2012cites this paper
• The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway.

  2012cites this paper
• Antimetastatic activity of pinosylvin, a natural stilbenoid, is associated with the suppression of matrix metalloproteinases.

  2012cites this paper
• Cyclooxygenase-2 inhibitors induce anoikis in osteosarcoma via PI3K/Akt pathway.

  2012cites this paper
• Prevalence of 5-Lipoxygenase Expression in Canine Osteosarcoma and the Effects of a Dual 5-Lipoxygenase/Cyclooxygenase Inhibitor on Osteosarcoma Cells In Vitro and In Vivo

  2012cites this paper
• Effects of Indomethacin, Nimesulide, and Diclofenac on Human MG-63 Osteosarcoma Cell Line

  2012cites this paper
• Anti-inflammatory agents suppress the prostaglandin E2 production and migration ability of cholangiocarcinoma cell lines.

  2012cites this paper
• Effect of Aspirin on Cell Growth of Human MG-63 Osteosarcoma Line

  2012cites this paper
• Effect of ibuprofen on proliferation, differentiation, antigenic expression, and phagocytic capacity of osteoblasts

  2012cites this paper
• Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells

  2012cites this paper
• Transition of Treatment for Patients with Extra-Abdominal Desmoid Tumors: Nagoya University Modality

  2012cites this paper
• 15-Deoxy-Δ12,14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species.

  2011cites this paper
• Anti-tumour effects by a trimodal combination of temozolomide, meloxicam and X-rays in cultures of human glioma cells

  2011cites this paper
• Effet des radiations sur la croissance tumorale chez le modèle de gliom e murin

  2011cites this paper
• RNAi-mediated knockdown of cyclooxygenase2 inhibits the growth, invasion and migration of SaOS2 human osteosarcoma cells: a case control study

  2011cites this paper
• Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer

  2011cites this paper
• Effective antiproliferative effect of meloxicam on prostate cancer cells: development of a new controlled release system.

  2010cites this paper
• Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case–control study

  2010cites this paper
• Characterization of a rat model of metastatic prostate cancer bone pain

  2010cites this paper
• Successful treatment with meloxicam, a cyclooxygenase-2 inhibitor, of patients with extra-abdominal desmoid tumors: a pilot study.

  2010cites this paper
• Antitumor effects of a cyclooxygenase-2 inhibitor, meloxicam, alone and in combination with radiation and/or 5-fluorouracil in cultured tumor cells.

  2009cites this paper
• Avaliation of carprofen and meloxicam as antipyretics in dogs.

  2009cites this paper
• Establishment and characterization of a novel human malignant peripheral nerve sheath tumor cell line, FMS-1, that overexpresses epidermal growth factor receptor and cyclooxygenase-2

  2009cites this paper
• YKL-40, a secreted glycoprotein, promotes tumor angiogenesis

  2009cites this paper
• Antigenic Phenotype and Phagocytic Capacity of MG‐63 Osteosarcoma Line

  2009cites this paper
• Ketoprofen in topical formulation decreases the matrix metalloproteinase‐2 expression and pulmonary metastatic incidence in nude mice with osteosarcoma

  2009cites this paper
• Cyclooxygenase-2 Overexpression Predicts Poor Survival in Patients with High-grade Extremity Osteosarcoma: A Pilot Study

  2009cites this paper
• Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis.

  2009cites this paper
• Effects of electroacupuncture in a mouse model of experimentally-induced osteosarcoma.

  2009cites this paper
• Role of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies

  2008cites this paper
• COX-2 Expression Correlates With Survival in Patients With Osteosarcoma Lung Metastases

  2008cites this paper
• Differential effects of selective cyclooxygenase-2 inhibitors in inhibiting proliferation and induction of apoptosis in oral squamous cell carcinoma.

  2008cites this paper